Browse the corpus

Dyspareunia is defined by persistent or recurrent genital pain that occurs before, during, or after sexual intercourse and represents a complex clinical condition with multifactorial origins. Classification as a sexual disorder or pain disorder remains debated, reflecting challenges in identifying a single underlying etiology. Potential contributors include gynecologic, urologic, musculoskeletal, neurologic, hormonal, and psychosocial factors, which frequently coexist. Dyspareunia can exert a substantial burden on physical functioning, emotional health, intimate relationships, and overall quality of life. Effective care requires recognition of the condition as a chronic and often biopsychosocial disorder that warrants comprehensive, patient-centered evaluation rather than symptom-focused management alone. This educational activity equips participants with a structured framework for evaluating dyspareunia through detailed medical, sexual, and psychosocial histories and targeted physical examination strategies. Learners develop skills to identify contributing factors, differentiate potential etiologies, and apply evidence-based diagnostic approaches. The course reviews current management options, including hormonal, behavioral, and multimodal therapies, with an emphasis on individualized treatment planning. Collaboration within an interprofessional healthcare team is essential for optimizing outcomes, supporting comprehensive assessment, coordinating care, and ensuring appropriate referral to subspecialty services. Participants also gain practical counseling strategies that validate patient experiences, strengthen therapeutic alliances, and promote sustained engagement in long-term care. Objectives: Identify key clinical features and contributing factors of dyspareunia through comprehensive medical, sexual, and psychosocial history-taking. Differentiate among potential etiologies of dyspareunia to guide individualized, patient-centered management. Apply evidence-based therapeutic options for dyspareunia, including hormonal, behavioral, and multimodal interventions. Collaborate with interprofessional team members, including pelvic-floor physical therapists, mental health professionals, and subspecialists, to support comprehensive care and improve outcomes for patients experiencing dyspareunia. Access free multiple choice questions on this topic.

Painful sexual intercourse or pain provoked by activity involving insertion into the vagina is known as dyspareunia; this is a common female health problem and a complex disorder that is often overlooked.[1] According to The American Psychiatric Association’s Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revised (DSM-5-TR; APA, 2022), dyspareunia is now combined with vaginismus into 1 of the 4 major categories of female sexual dysfunction, called genitopelvic pain-penetration disorder (GPPPD).[2] The definition of GPPPD is marked pain during intercourse or vaginal penetration attempts,  tightening of the vaginal muscles with decreased ability to accommodate penetration, tension, pain, or burning felt when penetration is attempted, and a decrease or no desire to have intercourse, resulting in avoidance of sexual activity or intense phobia of pain. These symptoms must be present for 6 months and cause significant distress to the patient.[3] According to the International Society for the Study of Women’s Sexual Health (ISSWSH), GPPPD encompasses not only pain or difficulty during penetration but also discomfort associated with any form of genital contact. This condition may involve increased tension or overactivity of the pelvic floor muscles, which can occur with or without direct genital stimulation.[4] The prevalence of dyspareunia ranges from 3% to 18% worldwide and can affect 10% to 28% of the population over a lifetime.[5][6] Dyspareunia can be further categorized into superficial or deep, and primary or secondary. Superficial dyspareunia is limited to the vulva or vaginal entrance, while deep dyspareunia involves pain in the deeper parts of the vagina or lower pelvis.[7] Deep dyspareunia is frequently associated with endometriosis and deep sexual penetration.[8] Primary dyspareunia is pain that initiates at the start of the patient having sexual intercourse, without a time of having pain-free vaginal penetration. Secondary dyspareunia is pain that begins after some time of pain-free sexual activity.[7]

The prevalence of dyspareunia ranges from 3% to 18% worldwide and can affect 10% to 28% of the population over a lifetime.[5][6] Dyspareunia can be further categorized into superficial or deep, and primary or secondary. Superficial dyspareunia is limited to the vulva or vaginal entrance, while deep dyspareunia involves pain in the deeper parts of the vagina or lower pelvis.[7] Deep dyspareunia is frequently associated with endometriosis and deep sexual penetration.[8] Primary dyspareunia is pain that initiates at the start of the patient having sexual intercourse, without a time of having pain-free vaginal penetration. Secondary dyspareunia is pain that begins after some time of pain-free sexual activity.[7] Dyspareunia may occur with vulvodynia, a genital pain that lasts longer than 3 months with or without the association of sexual intercourse.[9] Dyspareunia can also lead to sexual difficulties, such as a lack of sexual desire and arousal, and can cause trouble in sexual relationships.[10] The condition can have a significant impact on physical as well as mental health and can lead to depression, anxiety, hypervigilance to pain, negative body image, and low self-esteem. Prompt management is therefore crucial when addressing this condition.[11][12][13]

Dyspareunia is a complex condition with causes that often overlap across multiple body systems. The etiology includes structural abnormalities, inflammatory and infectious processes, hormonal changes, neoplastic conditions, trauma, and musculoskeletal issues such as pelvic floor dysfunction. Neurological disorders, psychological stress or trauma, interpersonal relationship dynamics, and sociocultural influences also play significant roles in its development.[14] The causes of dyspareunia can be broadly classified. Physical and/or organic causes of dyspareunia include anatomical and structural abnormalities, hormonal factors, inflammatory and infectious conditions, neoplastic causes, musculoskeletal disorders, neurologic causes, and trauma. Anatomical and structural abnormalities that can cause dyspareunia include congenital abnormalities such as vaginal agenesis or vaginal septum. Scarring, adhesions, and endometriosis are acquired changes that cause anatomical and structural abnormalities that may contribute to dyspareunia. Hormonal factors include hormonal therapies, such as contraceptives and states of estrogen deficiency, which not only occur in menopause but also in postpartum and lactating individuals. Inflammatory and infectious conditions that may cause dyspareunia include vulvovaginal candidiasis, bacterial vaginosis, trichomoniasis, pelvic inflammatory disease, and urinary tract infections. Vulvar or vaginal cancers and benign masses or cysts, such as Bartholin's cysts, are neoplastic causes of dyspareunia. Musculoskeletal disorders such as pelvic floor dysfunction, myofascial pain, and postural or spinal misalignments can all cause dyspareunia. Neurologic causes of dyspareunia include pudendal neuralgia and central sensitization, seen in fibromyalgia patients. Lastly, trauma occurring from sexual assault or abuse, childbirth, and surgical injuries may contribute to dyspareunia. Again, dyspareunia frequently has multiple etiologies, and the causes may involve multiple organ systems.

Musculoskeletal disorders such as pelvic floor dysfunction, myofascial pain, and postural or spinal misalignments can all cause dyspareunia. Neurologic causes of dyspareunia include pudendal neuralgia and central sensitization, seen in fibromyalgia patients. Lastly, trauma occurring from sexual assault or abuse, childbirth, and surgical injuries may contribute to dyspareunia. Again, dyspareunia frequently has multiple etiologies, and the causes may involve multiple organ systems. Psychological and emotional factors that cause dyspareunia include anxiety, depression, post-traumatic stress disorder, body image issues, fear, pain, or performance anxiety, and a history of sexual trauma or abuse. Psychological and emotional factors play a significant role in the onset and persistence of dyspareunia, often interacting with physical causes to exacerbate pain. Anxiety, particularly related to sexual performance or fear of pain, can lead to involuntary pelvic floor muscle tension, creating a cycle where anxiety heightens physical discomfort during intercourse. Depression may reduce sexual desire and arousal, leading to decreased lubrication and increased sensitivity to pain. A history of sexual trauma or abuse is a well-documented psychological contributor, often resulting in fear, emotional detachment, or hypervigilance during intimacy. Additionally, negative body image, low self-esteem, and unresolved relational conflicts can impair emotional connection and physical relaxation, making intercourse painful. Feelings of shame or guilt associated with cultural or religious beliefs about sex may further inhibit arousal and contribute to psychological distress during sexual activity. These factors can culminate in a self-reinforcing loop of pain, anxiety, and muscular tension, complicating both the diagnosis and treatment of dyspareunia.

Depression may reduce sexual desire and arousal, leading to decreased lubrication and increased sensitivity to pain. A history of sexual trauma or abuse is a well-documented psychological contributor, often resulting in fear, emotional detachment, or hypervigilance during intimacy. Additionally, negative body image, low self-esteem, and unresolved relational conflicts can impair emotional connection and physical relaxation, making intercourse painful. Feelings of shame or guilt associated with cultural or religious beliefs about sex may further inhibit arousal and contribute to psychological distress during sexual activity. These factors can culminate in a self-reinforcing loop of pain, anxiety, and muscular tension, complicating both the diagnosis and treatment of dyspareunia. Relational and sociocultural influences that cause dyspareunia include relationship conflict or lack of emotional intimacy, cultural or religious beliefs about sex, and misinformation or lack of sexual education. Relational and sociocultural influences play a critical role in the development and persistence of dyspareunia. Within intimate relationships, poor communication, unresolved conflict, emotional disconnection, and lack of trust can all contribute to increased physical tension and decreased sexual satisfaction, which may manifest as pain during intercourse. When individuals feel coerced or obligated to engage in sexual activity, whether due to explicit pressure or implicit expectations, this can lead to anxiety, reduced arousal, and involuntary muscular guarding. Sociocultural factors further compound these issues. Cultural and religious beliefs that frame sex as shameful or morally restrictive can instill fear, guilt, or repression surrounding sexual activity, while traditional gender roles and sexual scripts may discourage open expression of pain or limit a woman's sexual autonomy. Additionally, limited access to accurate sexual education can result in misconceptions about normal sexual function and a lack of awareness that pain during intercourse is treatable.

When individuals feel coerced or obligated to engage in sexual activity, whether due to explicit pressure or implicit expectations, this can lead to anxiety, reduced arousal, and involuntary muscular guarding. Sociocultural factors further compound these issues. Cultural and religious beliefs that frame sex as shameful or morally restrictive can instill fear, guilt, or repression surrounding sexual activity, while traditional gender roles and sexual scripts may discourage open expression of pain or limit a woman's sexual autonomy. Additionally, limited access to accurate sexual education can result in misconceptions about normal sexual function and a lack of awareness that pain during intercourse is treatable. Multifactorial and  overlapping causes of dyspareunia are common; therefore, a holistic approach to the assessment and treatment of the individual is essential. Understanding the general etiologies of dyspareunia provides a helpful framework, but examining specific conditions within these categories offers greater insight into their mechanisms and clinical implications. Having outlined the broad categories of causes of dyspareunia, the following specific examples within each domain illustrate how these factors contribute to dyspareunia in clinical practice. One of the most common etiologies of dyspareunia is endometriosis, a condition in which endometrial glands and stroma are present outside the uterus. The etiology of endometriosis-associated deep dyspareunia may be due to endometriosis-specific factors or indirect contributors like bladder or pelvic floor dysfunction. In women, regardless of the staging of endometriosis, the severity of deep dyspareunia has been strongly associated with bladder and pelvic floor tenderness and painful bladder syndrome, independent of endometriosis-specific factors. This connection suggests the role of myofascial or sensitization pain mechanisms in some women with deep dyspareunia.[15]

One of the most common etiologies of dyspareunia is endometriosis, a condition in which endometrial glands and stroma are present outside the uterus. The etiology of endometriosis-associated deep dyspareunia may be due to endometriosis-specific factors or indirect contributors like bladder or pelvic floor dysfunction. In women, regardless of the staging of endometriosis, the severity of deep dyspareunia has been strongly associated with bladder and pelvic floor tenderness and painful bladder syndrome, independent of endometriosis-specific factors. This connection suggests the role of myofascial or sensitization pain mechanisms in some women with deep dyspareunia.[15] Endometriosis in the posterior cul-de-sac, in particular, is associated with deep dyspareunia. In a cross-sectional study of 940 women, almost 45% of patients with surgically diagnosed endometriosis reported deep dyspareunia.[16] Adenomyosis is another cause of dyspareunia.[17] In patients with rectovaginal septum endometriosis undergoing surgery for painful intercourse, the presence of adenomyosis significantly diminishes the degree of symptom improvement postoperatively. Consequently, incorporating thorough preoperative evaluation for adenomyosis—using imaging modalities such as transvaginal ultrasound or magnetic resonance imaging (MRI)—can enhance surgical planning and improve patient outcomes.[18] Pelvic venous disorders, including pelvic congestion syndrome, are a prevalent pathology in young, multiparous women and are accompanied by chronic pelvic pain that may also include dyspareunia. Congestion is noted in the pelvic venous structures.[19] Radiation therapy is a commonly used treatment modality for pelvic malignancies, including colorectal cancers and cervical cancers. With these treatments, some radiation of the surrounding tissues occurs, causing vascular damage and changes in tissue composition that can lead to tissue damage, including late radiation tissue injury of the vagina. Because of this, dyspareunia is reported in 25% to 68% of patients treated for anal cancer.[20]

Pelvic venous disorders, including pelvic congestion syndrome, are a prevalent pathology in young, multiparous women and are accompanied by chronic pelvic pain that may also include dyspareunia. Congestion is noted in the pelvic venous structures.[19] Radiation therapy is a commonly used treatment modality for pelvic malignancies, including colorectal cancers and cervical cancers. With these treatments, some radiation of the surrounding tissues occurs, causing vascular damage and changes in tissue composition that can lead to tissue damage, including late radiation tissue injury of the vagina. Because of this, dyspareunia is reported in 25% to 68% of patients treated for anal cancer.[20] Dermatologic diseases such as lichen planus, lichen sclerosis, and psoriasis can also cause significant inflammation of the vaginal mucosa. Perivaginal and pelvic infections such as urethritis, vaginitis, and pelvic inflammatory disease can result from gonorrhea, chlamydia, candida, trichomoniasis, bacterial vaginosis, and viral pathogens such as herpes. One of the frequent contributors to dyspareunia is pelvic floor dysfunction, commonly associated with painful trigger points and muscle overactivity.[21] Lack of vaginal lubrication may lead to dyspareunia. This problem is most common in reproductive years and is attributable to hormonal as well as sexual arousal disorders. For reproductive-aged females, hormonal contraceptives can cause inadequate lubrication. The decreased estrogen levels noted in postmenopausal women can cause vaginal atrophy by thinning the vaginal mucosa that is responsible for promoting vaginal secretions. Vaginismus is a condition characterized by involuntary contraction of the pelvic floor muscles during attempted vaginal penetration, leading to pain and difficulty with penetration. This is considered both a musculoskeletal and psychosexual cause of dyspareunia, more commonly seen in younger women. Vaginismus, along with dyspareunia, falls under the broader diagnostic category of GPPPD. The condition may result from pelvic floor dysfunction or be linked to psychosocial factors such as a history of sexual trauma, anxiety, or negative sexual experiences.[22] Dyspareunia is more commonly seen in women who have a history of sexual abuse.[23]

Vaginismus is a condition characterized by involuntary contraction of the pelvic floor muscles during attempted vaginal penetration, leading to pain and difficulty with penetration. This is considered both a musculoskeletal and psychosexual cause of dyspareunia, more commonly seen in younger women. Vaginismus, along with dyspareunia, falls under the broader diagnostic category of GPPPD. The condition may result from pelvic floor dysfunction or be linked to psychosocial factors such as a history of sexual trauma, anxiety, or negative sexual experiences.[22] Dyspareunia is more commonly seen in women who have a history of sexual abuse.[23] Postpartum dyspareunia is a highly prevalent condition affecting many women after childbirth, often resulting from physical changes such as perineal trauma, vaginal dryness, or pelvic floor muscle dysfunction. Healing from episiotomies, tears, or cesarean sections can contribute to discomfort during intercourse, while hormonal shifts in the postpartum period may also influence tissue sensitivity and lubrication. Lactational dyspareunia refers explicitly to painful intercourse during breastfeeding and is primarily due to estrogen suppression caused by lactation. Lower estrogen levels lead to vaginal atrophy, dryness, and thinning of the vaginal walls, which can increase friction and discomfort during sex. Both conditions are typically temporary but may require medical or therapeutic intervention if symptoms persist.

Postpartum dyspareunia is a highly prevalent condition affecting many women after childbirth, often resulting from physical changes such as perineal trauma, vaginal dryness, or pelvic floor muscle dysfunction. Healing from episiotomies, tears, or cesarean sections can contribute to discomfort during intercourse, while hormonal shifts in the postpartum period may also influence tissue sensitivity and lubrication. Lactational dyspareunia refers explicitly to painful intercourse during breastfeeding and is primarily due to estrogen suppression caused by lactation. Lower estrogen levels lead to vaginal atrophy, dryness, and thinning of the vaginal walls, which can increase friction and discomfort during sex. Both conditions are typically temporary but may require medical or therapeutic intervention if symptoms persist. Labial posterior commissure deformities are another significant etiology of superficial dyspareunia that stems from structural irregularities in the vulva or vaginal entrance, especially at the posterior commissure. In this area, the labia majora and minora converge near the perineal body. The posterior fourchette, a delicate skin fold at the back of the vaginal opening, is particularly vulnerable to friction and stress. When this area is unusually positioned—either elevated naturally or displaced during intercourse—an adjacent vestibular depression can develop, placing undue tension on the fourchette. Repeated mechanical strain may result in microtears and subsequent scar formation, which decreases tissue flexibility, provokes chronic pain, and ultimately impairs sexual function, often fostering avoidance and diminished quality of life. These deformities fall into 2 main categories: postinflammatory, driven by prior inflammation or injury, and anatomical, rooted in congenital structural variation.[24]

Worldwide, dyspareunia affects 8% to 56% of women and an unknown percentage of gender expansive people.[2][14] The incidence of dyspareunia mainly depends on the definition used and the population sampled. In the United States, the prevalence ranges from 7% to 46%. Although more common in women, dyspareunia also affects men. Women with symptoms severe enough to require medical attention comprise a small subset, as most patients do not seek medical attention, making the true incidence rather challenging to determine.[22] Sexual pain is also more commonly associated with other conditions that cause pain, such as irritable bowel syndrome, musculoskeletal disorders, and fibromyalgia.[25] While it is hard to determine precisely how many perimenopausal and postmenopausal women experience painful intercourse, it is broadly underreported. When pain is linked to genitourinary syndrome of menopause or vulvovaginal atrophy, estimates suggest between 40% and 84% of women are affected. These conditions are the most frequent causes of dyspareunia in postmenopausal women.[26] Dyspareunia is commonly reported in the first postpartum year, with a pooled prevalence of approximately 35%, which decreases over time. At 2 to 6 months postpartum, approximately 42% of women experience pain during intercourse, and nearly half report resuming sexual activity with discomfort within 2 to 3 months after delivery. Although symptoms often improve, a significant number of women, particularly those who experienced more severe perineal trauma, continue to report pain beyond 1 year. Between 6 and 12 months postpartum, 22% to 32% of women still experience dyspareunia. The condition is less common in women who have uncomplicated vaginal deliveries with either an intact perineum or unsutured minor tears. At 3 months postpartum, 64% report some level of discomfort during intercourse, with 16.1% experiencing it often or always; by 12 months, these numbers decline to 54% and 8.5%, respectively. Women with second-degree perineal tears tend to delay resuming sexual activity by about a month compared to those with no tear or only a first-degree tear. While dyspareunia is elevated across all tear categories, severity within second-degree tears does not significantly alter prevalence; however, those with more extensive second-degree trauma report the highest rates of persistent pain.[27][28]

The pathophysiology of dyspareunia is multifactorial, involving peripheral and central mechanisms, local tissue inflammation, and hormonal deficiencies. Nerve sensitization may contribute to peripheral pain. Central sensitization, a heightened nervous system response to stimulation, may develop and amplify pain perception. Muscle hypertonicity in the pelvic floor and psychological factors may further perpetuate and intensify the pain cycle. The most common findings in patients with dyspareunia include localized or deep pelvic pain during or after intercourse, increased muscle tension in the pelvic floor, and tenderness on physical exam in the vestibule, vaginal sidewalls, or pelvic musculature. Pain with intercourse is more prevalent in patients with dysmenorrhea and bladder hypersensitivity, which suggests a visceral hypersensitivity mechanism may be involved in dyspareunia.[29] Patients may report burning, stinging, or sharp pain with penetration that can result in avoidance behaviors, sexual distress, and anxiety.

In patients presenting with dyspareunia, obtaining a nonjudgmental history is crucial and should include pain descriptors: duration, intensity, location, exacerbating and alleviating factors, and any associated psychological components. The location and onset of pain can help differentiate entry pain from deep pain. Whereas a burning pain is more commonly linked to vaginitis, vulvodynia, atrophy, or inadequate lubrication, a deep aching pain may be noted in pelvic congestion syndrome, pelvic inflammatory disease, endometriosis, uterine fibroids, and adnexal pathology. A situational versus a more generalized description (applicable only to certain partners or to all encounters) may more strongly relate to psychological considerations.[30] The Initial Measurement of Patient-Reported Pelvic Floor Complaints Tool (IMPACT) form may be helpful, as it consists of a questionnaire relevant to pelvic floor abnormalities.[31] Other validated tools that can assist with the diagnosis of dyspareunia include the Female Sexual Function Index and the Female Sexual Distress Scale-Revised.[32] A thorough clinical assessment of GPPPD begins with a detailed sexual and pain history. Key elements include identifying the location of the pain, whether it is superficial (eg, at the vulvar vestibule), external, internal, or deep within the pelvis. Clinicians should inquire about specific triggers, such as types of sexual activity, particular positions, or whether the pain is provoked by contact or occurs spontaneously. Understanding what alleviates pain, if anything, can also inform the diagnosis and management. Patients should be encouraged to describe the quality of pain using terms such as burning, stabbing, throbbing, or aching to characterize its nature. An essential aspect of the evaluation is the exploration of the emotional impact of the pain, including the degree of distress it causes. There is also a necessity to determine whether the pain is persistent across most or all sexual experiences, or situational, and whether it precedes or follows any coexisting sexual dysfunction, such as low desire or difficulty with arousal or orgasm. These components form the basis for a tailored, multidisciplinary approach to diagnosis and treatment.[4]

Patients should be encouraged to describe the quality of pain using terms such as burning, stabbing, throbbing, or aching to characterize its nature. An essential aspect of the evaluation is the exploration of the emotional impact of the pain, including the degree of distress it causes. There is also a necessity to determine whether the pain is persistent across most or all sexual experiences, or situational, and whether it precedes or follows any coexisting sexual dysfunction, such as low desire or difficulty with arousal or orgasm. These components form the basis for a tailored, multidisciplinary approach to diagnosis and treatment.[4] In patients with dyspareunia, the pelvic examination should assess the vulva, vagina, pelvic organs, and pelvic floor. In the first step of physical examination, it is always advisable to educate the patient about the examination and her anatomy.[33] The exam should begin with a visual inspection of the labia majora and labia minora, vestibular area, anus, and urethral orifice to evaluate for any lesions, labial hypertrophy, leukoplakia, or erythema. The speculum exam should be performed after selecting an appropriately sized, warmed, and lubricated speculum. The cervix should be examined for any associated lesions, erythema, and discharge, at which time appropriate cultures can be obtained. The bimanual examination should then evaluate for any adnexal masses, uterine enlargement or irregularity in contour, and additional anatomic variants.[34][35][36] A vaginal examination using a single digit and palpation at the 4 to 5 and 7 to 8 o'clock positions may elicit tenderness or high pelvic tone associated with pelvic floor dysfunction.[25] Given that patients rarely bring up sexual discomfort on their own, clinicians need to initiate the conversation. Many women mistakenly think that pain during sex is a normal, untreatable part of aging, and therefore, they often don't mention it unless asked.[26] Large-scale studies like the Study of Women's Health Across the Nation show that painful intercourse does increase during menopause. However, the data only covers women up to about the age of 52 who are sexually active. Most existing reviews on dyspareunia include only women younger than 60. This misses a crucial fact: many women retain interest in sexual activity into their 60s, 70s, and even 80s.

Laboratory evaluation rarely helps in guiding the diagnosis or treatment of dyspareunia. The Vaginal Penetration Skills Scale (VPSS) is a 3-part self-report tool designed to screen for, assess, and categorize GPPPD. Both versions, the longer VPSS-29 and the shorter VPSS-SF11, have been validated and can be completed by patients themselves or used in clinical settings. Each version has value in both clinical practice and research. The VPSS-29 provides a detailed assessment of GPPPD symptoms, thereby helping clinicians develop personalized treatment plans. In contrast, the VPSS-SF11 is a shorter screening tool that may help identify women who could have GPPPD. A score of 45 or less on the VPSS-SF11 suggests the need for further evaluation, including the full VPSS-29. Because it is quicker to complete, the VPSS-SF11 is particularly useful in time-limited clinical or research settings. Additionally, both versions can help classify the severity of GPPPD based on symptom levels.[2] Since the pain in vulvodynia is similar to dyspareunia, it is helpful to differentiate this by performing a cotton swab test during the vulvar examination.[33] The cotton swab test involves applying gentle pressure to the vulva and having the patient rate pain as the cotton swab is applied to multiple areas.[37] Further tests can include pelvic cultures for gonorrhea, chlamydia, trichomoniasis, Candida, and Gardnerella, especially when women present with vaginal or cervical discharge. Genital ulcers can be tested for herpes simplex, syphilis, or appropriately cultured. Women with dysuria, urgency, frequency, or suprapubic discomfort should undergo urinalysis. Visible lesions noted on physical exam should undergo tissue biopsy.[38] A transvaginal ultrasound can help evaluate pelvic masses, ovarian cysts, or congenital anomalies. A vaginal pH of 6.0 to 7.5 is strongly suggestive of vaginal atrophy. This can be readily tested by placing a pH paper strip along the lateral wall of the vagina. Vaginal dilators serve a crucial diagnostic purpose. By inserting a series of graduated dilators, clinicians can objectively assess a patient’s capacity for penetration. This sequential approach reveals how effectively the patient tolerates progressively larger devices, helping to uncover involuntary pelvic floor muscle spasms associated with vaginismus.[26]

Effective management of GPPPD necessitates an individualized, multidisciplinary approach that addresses both somatic and psychological contributing factors. Collaboration among healthcare professionals, including sexual health counselors, clinical psychologists, pelvic floor physical therapists, and pain management specialists, is often required. Psychological comorbidities, such as anxiety, are frequently observed and may compound the clinical presentation. These disorders also commonly co-occur with other forms of sexual dysfunction, including diminished arousal and, in more advanced cases, anorgasmia, which may require further specialized intervention.[3] For the treatment of dyspareunia, a multimodal approach is advantageous for addressing all aspects of pain (physical, emotional, and behavioral). Treatment should involve a team specializing in chronic pain.[39] In the first step, a clinician should acknowledge the patient's pain. The patient should receive counsel that pain management may take time, and it is quite possible that it may not completely resolve even after the completion of treatment. Patients should be informed in detail of all available treatment options and guided in selecting the most appropriate option. A conservative nonsurgical approach should be the first step. Treatment may include patient education about the condition, avoidance or modifications of irritants or triggers, use of vaginal lubricants and moisturizers, hormone therapy, pelvic floor physical therapy, and psychosocial interventions as indicated.[40] Pelvic floor physical therapy, also known as physiotherapy for pelvic muscles, is considered an effective intervention for GPPPD, as it facilitates the restoration of pelvic muscle function and alleviates associated pain. Pelvic floor physical therapy can serve as an adjuvant treatment option in most cases of dyspareunia. This therapy relaxes the pelvic floor muscles and resets the pain receptors.[41] Perineal muscle training offers several benefits: it improves relaxation, restores baseline muscle activity, enhances vaginal elasticity, and boosts muscle awareness. These effects may help repair tissue damage linked to pelvic pain and dysfunction. Additionally, weak perineal muscles have been associated with difficulty reaching orgasm, a common issue associated with dyspareunia.[7]

Pelvic floor physical therapy, also known as physiotherapy for pelvic muscles, is considered an effective intervention for GPPPD, as it facilitates the restoration of pelvic muscle function and alleviates associated pain. Pelvic floor physical therapy can serve as an adjuvant treatment option in most cases of dyspareunia. This therapy relaxes the pelvic floor muscles and resets the pain receptors.[41] Perineal muscle training offers several benefits: it improves relaxation, restores baseline muscle activity, enhances vaginal elasticity, and boosts muscle awareness. These effects may help repair tissue damage linked to pelvic pain and dysfunction. Additionally, weak perineal muscles have been associated with difficulty reaching orgasm, a common issue associated with dyspareunia.[7] Myofascial release to treat trigger points should be considered, as trigger points are one of the etiological factors of dyspareunia. Thiele massage is a manual therapy technique used to treat pelvic pain caused by muscle tension or trigger points in the pelvic floor. It involves internal digital massage—usually through the rectum or vagina—using rhythmic, circular motions to release tightness in muscles like the levator ani. This technique helps reduce muscle spasms, improve blood flow, and relieve chronic pelvic pain conditions such as dyspareunia, levator ani syndrome, or pelvic floor dysfunction. A trained pelvic floor physical therapist typically performs the Thiele massage, which is often combined with other treatments like stretching, relaxation techniques, and muscle retraining for optimal results.[7] Botulinum toxin injection has proved to be effective in the treatment of dyspareunia caused by pelvic floor myalgia and contracture.[42][43] Cognitive-behavioral therapy has shown promising results in reducing anxiety and fear related to dyspareunia. This therapy is the most commonly used behavioral intervention and is strongly recommended.[44] Surgical treatment is adopted as a last resort when all conservative medical and behavioral treatment options have failed. Surgery is useful in identifying and/or treating pelvic adhesions, endometriosis, and pelvic organ prolapse.[45]

A trained pelvic floor physical therapist typically performs the Thiele massage, which is often combined with other treatments like stretching, relaxation techniques, and muscle retraining for optimal results.[7] Botulinum toxin injection has proved to be effective in the treatment of dyspareunia caused by pelvic floor myalgia and contracture.[42][43] Cognitive-behavioral therapy has shown promising results in reducing anxiety and fear related to dyspareunia. This therapy is the most commonly used behavioral intervention and is strongly recommended.[44] Surgical treatment is adopted as a last resort when all conservative medical and behavioral treatment options have failed. Surgery is useful in identifying and/or treating pelvic adhesions, endometriosis, and pelvic organ prolapse.[45] Medical treatment options available for dyspareunia include oral tricyclic antidepressants, oral or topical hormonal replacement, and oral nonsteroidal anti-inflammatory drugs. Treatment of dyspareunia depends on the etiology of the patient's complaint. Dyspareunia due to postmenopausal vaginal atrophy can be treated with systemic but primarily topical hormone replacement therapy, selective estrogen receptor modulator therapy (ospimifene), and the use of vaginal dehydroepiandrosterone.[46][47][48] For pain relief, topical lidocaine can be applied locally. In contrast, neuropathic pain medications such as amitriptyline, gabapentin, or pregabalin may be used when nerve pain or muscle spasms contribute to discomfort. In some cases, other treatments, such as duloxetine or botulinum toxin injections into the pelvic floor muscles, may be considered. Clinicians treat infectious causes with the appropriate antibiotic, antifungal, or antiviral therapy based on culture results. Because dyspareunia often has multiple causes, a tailored, multidisciplinary approach is essential for effective management.[49]

In contrast, neuropathic pain medications such as amitriptyline, gabapentin, or pregabalin may be used when nerve pain or muscle spasms contribute to discomfort. In some cases, other treatments, such as duloxetine or botulinum toxin injections into the pelvic floor muscles, may be considered. Clinicians treat infectious causes with the appropriate antibiotic, antifungal, or antiviral therapy based on culture results. Because dyspareunia often has multiple causes, a tailored, multidisciplinary approach is essential for effective management.[49] In the postpartum individual with dyspareunia, treatment modalities such as intravaginal myofascial release, massage, biofeedback, electrotherapy, and supervised pelvic floor muscle training have demonstrated efficacy in reducing muscle tension, improving proprioception, and alleviating pain, thereby enhancing sexual function and quality of life. A multimodal, individualized therapy approach delivered by a skilled pelvic health professional is essential to adequately address these complex, multifactorial presentations. Vibrating vaginal cones may have potential benefits for improving sexual satisfaction and reducing dyspareunia in postpartum women.[21] A single vibrating vaginal cone, made of medical-grade silicone to minimize irritation, is used to support pelvic floor training. Weighing 37 grams, its smooth, seamless design allows for easy, comfortable insertion about 3 cm into the vaginal canal with lubricant. The device uses gravity and internal vibration from a steel ball to trigger involuntary muscle contractions and provide biofeedback, enhancing pelvic floor coordination. Patients may use it for 1 hour per day during light activity, with periodic supervision to ensure proper use and effectiveness.[21]

In the postpartum individual with dyspareunia, treatment modalities such as intravaginal myofascial release, massage, biofeedback, electrotherapy, and supervised pelvic floor muscle training have demonstrated efficacy in reducing muscle tension, improving proprioception, and alleviating pain, thereby enhancing sexual function and quality of life. A multimodal, individualized therapy approach delivered by a skilled pelvic health professional is essential to adequately address these complex, multifactorial presentations. Vibrating vaginal cones may have potential benefits for improving sexual satisfaction and reducing dyspareunia in postpartum women.[21] A single vibrating vaginal cone, made of medical-grade silicone to minimize irritation, is used to support pelvic floor training. Weighing 37 grams, its smooth, seamless design allows for easy, comfortable insertion about 3 cm into the vaginal canal with lubricant. The device uses gravity and internal vibration from a steel ball to trigger involuntary muscle contractions and provide biofeedback, enhancing pelvic floor coordination. Patients may use it for 1 hour per day during light activity, with periodic supervision to ensure proper use and effectiveness.[21] In postmenopausal individuals experiencing moderate-to-severe dyspareunia attributable to GSM, therapeutic options such as vaginal moisturizers, low-dose vaginal estrogen, intravaginal prasterone, and oral ospemifene have demonstrated clinical utility. Intravaginal prasterone is dehydroepiandrosterone (DHEA), a steroid hormone mainly produced by the adrenal gland. Additionally, the use of vaginal lubricants and topical anesthetics may provide symptomatic relief. Treatments that have been found to have no benefit when dyspareunia is from GSM include vaginal testosterone, systemic DHEA, vaginal oxytocin, and oral raloxifene or bazedoxifene.[50] The application of fractional CO2 vaginal laser therapy for dyspareunia related to GSM is not currently recommended outside of rigorously controlled research settings.[3] Laser therapy, including fractional CO2, should not be used for the treatment of dyspareunia due to GSM until clinical studies show a minimal clinical difference with this treatment. Current randomized controlled trials do not support the efficacy of this therapy.[51]

The application of fractional CO2 vaginal laser therapy for dyspareunia related to GSM is not currently recommended outside of rigorously controlled research settings.[3] Laser therapy, including fractional CO2, should not be used for the treatment of dyspareunia due to GSM until clinical studies show a minimal clinical difference with this treatment. Current randomized controlled trials do not support the efficacy of this therapy.[51] Radiation-induced dyspareunia from the treatment of pelvic cancers, like cervical and colon cancers, has been under investigation with the treatment of hyperbaric oxygen therapy. This hyperoxygenation leads to neoangiogenesis, reduced inflammation, increased collagen synthesis, and, consequently, improved wound healing. Hyperbaric oxygen therapy may be considered for the treatment of dyspareunia in patients with previous radiation therapy.[20]

Establishing an accurate diagnosis of dyspareunia can be challenging, as its symptoms often overlap with those of other conditions. A careful differential diagnosis, guided by a thorough history and physical examination, is essential to exclude alternative causes before confirming the diagnosis of dyspareunia. Some of these diseases and conditions are as follows: Vaginismus Atrophic vulvovaginitis Vulvar vestibulitis Endometriosis Pelvic adhesions Infectious vaginitis Adnexal mass Cervicitis Pelvic congestion (venous disorder) Interstitial cystitis Pelvic inflammatory disease, endometritis Other urogenital tract infections Adenomyosis Uterine leiomyomas Pelvic floor dysfunction Levator ani syndrome Coccygodynia Pelvic nerve entrapment Myofascial pain Lichen planus Somatic symptom disorder Psychogenic pelvic pain Lichen sclerosis Contact dermatitis Vulvodynia Post-traumatic stress disorder

The prognosis for dyspareunia depends on the underlying cause. If the underlying cause is known and curable, then dyspareunia has a better prognosis. The prognosis is poor in idiopathic dyspareunia. Treatment can last several months, and complete resolution is not guaranteed. Results from studies suggest that treatment outcomes typically emerge after at least 3 months. Thereafter, the patient's distress decreases, accompanied by an improved quality of life. Pelvic floor rehabilitation has shown promising results in the treatment of dyspareunia.[52] A 24-month follow-up is recommended for the best results.[53]

Dyspareunia is typically a treatable disease and does not result in significant complications; however, psychiatric issues may arise if dyspareunia remains untreated. Major depression due to dyspareunia may result, especially in younger women. In very few cases, fear of pain during sexual activity can result in female infertility.[54] Regardless of the disease's nonmalignant nature, timely management and intervention are crucial to prevent distressing sequelae. If the patients do not seek prompt, appropriate medical care, dyspareunia can result in significant distress, loss of sexual interest, and problems with relationships.

Clinicians seeking mental health professionals with expertise in sex therapy or the psychological management of female sexual dysfunction may refer to professional directories available through organizations such as the Society for Sex Therapy and Research, the American Association of Sexuality Educators, Counselors, and Therapists, or the International Society for the Study of Women’s Sexual Health.[4]

In general, patients are hesitant to discuss sexual dysfunction, and issues may go unnoticed for a long time.[55] Patients should be encouraged to discuss sexual health with their medical provider. Dyspareunia is a challenging topic for discussion for both the patient and the physician, which may result in suboptimal management. Clinicians require adequate education and training to evaluate and treat dyspareunia effectively.[55] Allaying patients' fears and providing reassurance so they can discuss this condition with their medical provider is essential, as the clinician can then refer them to specialists to guide treatment based on the clinical circumstances. Deterrence and patient education regarding dyspareunia focus on promoting open communication about sexual health, early recognition of symptoms, and timely medical evaluation. Educating women on the normal changes that can affect sexual function, such as hormonal shifts, childbirth, and aging, can help reduce stigma, encourage help-seeking behavior, and prevent chronic pain through early intervention. Emphasizing the importance of addressing both physical and emotional aspects of pain is essential for effective management and recovery.

To standardize treatment and bridge gaps among specialists, the Pelvic Floor Disorder Consortium (PFDC) was established in 2018. The PFDC is comprised of urogynecologists, urologists, gynecologists, physiotherapists, gastroenterologists, radiologists, physical therapists, and other advanced care clinicians who deal with complex concerns of sexual dysfunction.[56] The PFDC is a multidisciplinary initiative developed under the American Society of Colon and Rectal Surgeons to improve the diagnosis, management, and care coordination of pelvic floor disorders. The PFDC fosters collaboration by developing consensus guidelines, diagnostic algorithms, and standardized reporting templates, particularly for imaging studies such as dynamic MRI and defecography. By promoting unified clinical language and interprofessional education, the consortium addresses the complexity of pelvic floor disorders, which often span multiple organ systems and specialties. The PFDC's efforts help reduce variability in care, enhance communication among healthcare professionals, and support evidence-based, patient-centered treatment strategies.[57]

Effective management of dyspareunia requires coordinated, patient-centered care involving physicians, advanced practitioners, nurses, pharmacists, mental health providers, and pelvic health specialists. Each team member plays a distinct role, from diagnosis and treatment to emotional support and education. Interprofessional communication and shared decision-making ensure clinical continuity and patient safety. Ethical, trauma-informed care, combined with clear responsibilities and collaborative strategies, enhances patient outcomes, reduces treatment delays, and improves overall interprofessional team performance.